首页 / 资源中心 / 客户发表文献

The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases

发表时间:2024-09-13 访问次数:4
文章推荐